Aug 23, 20212 min readCANCER RESEARCHApalutamide plus ADT improves overall survival in metastatic castration-sensitive prostate cancer
Apr 19, 20216 min readINTERVIEWSWe spoke with Roldán Cortés, Director of Development and Marketing of MEDSIR
Sep 18, 20202 min readANNOUNCEMENTSDr. Joan Carles Galcerán presents results from the EXCAAPE clinical trial at ESMO 2020